CSIMarket
 


Biotechnology & Pharmaceuticals Industry Profitability

Profitability Information & Trends 
  
Industry:   Category:   Period:  

Biotechnology & Pharmaceuticals Industry Profitability Ratios 1 Q 2022 4 Q 2021 3 Q 2021 2 Q 2021 1 Q 2021
  2022 2021 2021 2021 2021
Gross Margin 69.36 % 70.88 % 70.69 % 68.96 % 70.52 %
Gross Margin Annual (TTM) 69.78 % 71.42 % 68.29 % 67.54 % 70.26 %
Gross Margin Ranking # 20 # 25 # 20 # 24 # 21
EBITDA Margin 26.54 % 34.37 % 36.58 % 29.3 % 32.91 %
EBITDA Margin Annual (TTM) 31.21 % 33.27 % 27.66 % 24.17 % 20.17 %
EBITDA Margin Ranking # 14 # 14 # 13 # 18 # 14
Operating Margin 16.97 % 26.24 % 29.35 % 27.62 % 25.43 %
Operating Margin Annual (TTM) 24.53 % 27.13 % 24.82 % 21.91 % 16.68 %
Operating Margin Ranking # 21 # 22 # 18 # 16 # 16
Pre-Tax Margin 15.55 % 24.12 % 25.16 % 17.49 % 18.99 %
Pre-Tax Margin Annual (TTM) 20.21 % 21.41 % 15.86 % 11.8 % 6.51 %
Pre-Tax Margin Ranking # 17 # 20 # 14 # 29 # 25
Net Margin 11.55 % 19.28 % 21.45 % 15.63 % 15.38 %
Net Margin Annual (TTM) 16.55 % 17.89 % 14.41 % 10.88 % 5.15 %
Net Margin Ranking # 19 # 22 # 14 # 27 # 25


Gross Margin Comment

Biotechnology & Pharmaceuticals Industry experienced contraction in Gross Profit by -8.02 % and Revenue by -7.18 %, while Gross Margin fell to 69.36 % below Industry's average Gross Margin.

On the trailing twelve months basis gross margin in 1 Q 2022 fell to 69.78 %.

Within Healthcare sector, Biotechnology & Pharmaceuticals Industry achieved the highest gross margin. Gross margin total ranking has deteriorated compare to previous quarter from to 20.

Note, first quarter Numbers include only companies who have reported first quarter earnings results. Numbers change as more businesses report financial results. See the full List.

Gross Margin Statistics
High Average Low
102.36 % 78.33 % 68.96 %
4. quarter 2013   2. quarter 2021

Gross Margin Industry Ranking
Within: No.
Healthcare Sector # 1
Overall # 20


Other Gross Margins
Compare Industry's gross margin to Asv's or S&P Gross profits within Biotechnology & Pharmaceuticals Industry
Highest Ranking Gross Margins Lowest Ranking Gross Margins
Profitability for Asv's Suppliers Definiton of Gross Margin

Biotechnology & Pharmaceuticals Industry EBITDA Margin Statistics

 
EBITDA Margin Statistics
High Average Low
47.91 % 28.68 % -6.51 %
4. quarter 2019   4. quarter 2018

EBITDA Margin Industry Ranking
Within: No.
Healthcare Sector # 1
Overall # 14

EBITDA Margin Comment

Biotechnology & Pharmaceuticals Industry experienced contraction in Ebitda by -29.68 % and Revenue by -7.18 %, while Ebitda Margin fell to 26.54 % below Industry's average Ebitda Margin.

On the trailing twelve months basis Ebitda Margin in 1 Q 2022 fell to 31.21 %.

Within Healthcare sector, Biotechnology & Pharmaceuticals Industry achieved highest ebitda margin. Ebitda margin total ranking has deteriorated compare to previous quarter from to 14.

Other EBITDA Margins
Compare Industry's EBITDA margin to Asv's or S&P Gross profits within Biotechnology & Pharmaceuticals Industry
Highest Ranking EBITDA Margins Lowest Ranking EBITDA Margins
Profitability for Industry's Suppliers Industry Net Cash Flow Margin


Biotechnology & Pharmaceuticals Industry Operating Margin Statistics

 
Operating Margin Comment

Biotechnology & Pharmaceuticals Industry experienced contraction in Operating Profit by -41.82 % and Revenue by -7.18 %, while Operating Margin fell to 16.97 % below Industry's average Operating Margin.

On the trailing twelve months basis operating margin in 1 Q 2022 fell to 24.53 %.

Within Healthcare sector only one Industry has achieved higher operating margin. Operating margin total ranking has deteriorated compare to previous quarter from to 21.



Operating Margin Statistics
High Average Low
41.3 % 25.06 % -10.83 %
4. quarter 2015   4. quarter 2018

Operating Margin Industry Ranking
Within: No.
Healthcare Sector # 2
Overall # 21

Biotechnology & Pharmaceuticals Industry Pre-Tax Margin Statistics

 


Pre-Tax Margin Statistics
High Average Low
38.85 % 20.39 % -12.75 %
4. quarter 2015   4. quarter 2018

Pre-Tax Margin Comment

Biotechnology & Pharmaceuticals Industry experienced contraction in Pre-Tax Income by -42.7 % and Revenue by -7.18 %, while Pre-Tax Margin fell to 15.55 % below Industry's average Pre-Tax Margin.

On the trailing twelve months basis Pre-Tax Margin in 1 Q 2022 fell to 20.21 %.

Within Healthcare sector only one Industry has achieved higher Pre-Tax Margin. Pre-Tax Margin total ranking has deteriorated compare to previous quarter from to 17.
Pre-Tax Margin Industry Ranking
Within: No.
Healthcare Sector # 2
Overall # 17

Pre-Tax Margins
Compare Industry's pre-tax margin to Asv's or S&P Net profits within Biotechnology & Pharmaceuticals Industry
Highest Ranking Net Margins Lowest Ranking Net Margins
Profitability for Asv's Competitors Industry Tax Rate


Biotechnology & Pharmaceuticals Industry Net Margin Statistics

 





Net Margin Comment

Biotechnology & Pharmaceuticals Industry experienced contraction in Net Profit by -47.19 % and Revenue by -7.18 %, while Net Margin fell to 11.55 % below Industry's average Net Margin.

On the trailing twelve months basis Net margin in 1 Q 2022 fell to 16.55 %.

Within Healthcare sector only one Industry has achieved higher Net margin. Net margin total ranking has deteriorated compare to previous quarter from to 19.

Net Margin Statistics
High Average Low
32.97 % 15.71 % -18.25 %
4. quarter 2015   4. quarter 2017
Net Margin Industry Ranking
Within: No.
Healthcare Sector # 2
Overall # 19

Other Net Margins
Compare Industry's net margin to Asv's or S&P Net profits within Biotechnology & Pharmaceuticals Industry
Highest Ranking Net Margins Lowest Ranking Net Margins
Profitability for Asv's Suppliers Definiton of Net Margin



       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

LION's Profile

Stock Price

LION's Financials

Business Description

Fundamentals

Charts & Quotes

LION's News

Suppliers

LION's Competitors

Customers & Markets

Economic Indicators

LION's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071